Cargando…
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
The CRISPR-Cas9 technology has changed the landscape of genome editing and has demonstrated extraordinary potential for treating otherwise incurable diseases. Engineering strategies to enable efficient intracellular delivery of CRISPR-Cas9 components has been a central theme for broadening the impac...
Autores principales: | Fang, Tianxu, Cao, Xiaona, Ibnat, Mysha, Chen, Guojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344766/ https://www.ncbi.nlm.nih.gov/pubmed/35918694 http://dx.doi.org/10.1186/s12951-022-01570-y |
Ejemplares similares
-
CRISPR/Cas9-mediated genome editing in nonhuman primates
por: Kang, Yu, et al.
Publicado: (2019) -
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021) -
CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017) -
CRISPR-Cas9: from Genome Editing to Cancer Research
por: Chen, Si, et al.
Publicado: (2016) -
CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)